Vani succeeds Sharad Tyagi, who retired from Boehringer Ingelheim India on December 31, 2020 after over a decade of successful and dedicated service to the Company. During his tenure, Sharad built Boehringer Ingelheim India to be one of India’s fastest growing multinational pharmaceutical companies.
Announcing Vani’s appointment, Thorsten Poehl, Head of Emerging Markets, Boehringer Ingelheim said, “India presents a unique opportunity for Boehringer Ingelheim, wherein we affirm our commitment to patients and people in the country with our products and services. Vani is a proven and respected leader who lives our Company values and has a strong track record of leading complex transformations and delivering results. With her unwavering commitment to patients, customers and employees, I am confident that Vani will lead the India business to build patient-friendly access and benefit models in the years to come.
Vani was formerly the Global Head of Boehringer Ingelheim’s Go-To-Market and Business Steering organization, based in the Company’s headquarters in Germany. She joined Boehringer Ingelheim in the US in 2011, working across Strategy & Operations, Marketing and Sales leadership roles before moving to Ingelheim in 2016 as Regional Business Manager for Japan. Her global experience in Healthcare spans nearly two decades across McKinsey & Company, Becton Dickinson and Boehringer Ingelheim, and is characterized by strong global mobility and cross-functional leadership assignments across Healthcare and Management Consulting. Prior to embarking on her international career, she served as a commissioned officer in the Indian Army Ordnance Corps.
Vani holds an MBA and MA in International Studies from the Wharton School at the University of Pennsylvania in Philadelphia, and a Bachelor’s degree with Honors in Chemistry from Delhi University.